Enfusion Inc
NYSE:ENFN
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.78
10.23
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Enfusion Inc
Enfusion Inc
Total Liabilities & Equity
Enfusion Inc
Total Liabilities & Equity Peer Comparison
CRM
PLTR
SNPS
INTU
ADBE
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Enfusion Inc
NYSE:ENFN
|
Total Liabilities & Equity
$109m
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Salesforce Inc
NYSE:CRM
|
Total Liabilities & Equity
$92.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
23%
|
CAGR 10-Years
26%
|
|
|
Palantir Technologies Inc
NYSE:PLTR
|
Total Liabilities & Equity
$4.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Synopsys Inc
NASDAQ:SNPS
|
Total Liabilities & Equity
$11.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Intuit Inc
NASDAQ:INTU
|
Total Liabilities & Equity
$32.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Total Liabilities & Equity
$30B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Enfusion Inc's Total Liabilities & Equity?
Total Liabilities & Equity
109m
USD
Based on the financial report for Dec 31, 2023, Enfusion Inc's Total Liabilities & Equity amounts to 109m USD.
What is Enfusion Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
41%
Over the last year, the Total Liabilities & Equity growth was -12%. The average annual Total Liabilities & Equity growth rates for Enfusion Inc have been 41% over the past three years .
You don't have any saved screeners yet
